Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sage Therapeutics Inc (SAGE)

  7. Sage Therapeutics Inc (SAGE) Financials

SAGE

Sage Therapeutics Inc

49.56
0.00 (0.0%)
Upgrade to Real-Time

Sage Therapeutics Inc. (SAGE) Fundamentals
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development.
SHARE INFORMATION
Market Cap$ 2,961,809,973
Shares Outstanding59,762,106
Float51,280,000
Percent Float85.81%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 3,294,000
Latest Fiscal EPS$ -2.46
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions564
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months3,304,709
Institutional Holdings Percent157.0%
Institutional Sold Previous 3 Months6,027,015
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months46,972
Insider Holdings Percent0.3
Insider Sold Previous 3 Months35,754
Insider Shares Owned199,184
TRADING INFO
52 Week High$ 54.86
52 Week Low$ 30.67
52 Week High Change$ 44.74
21 Day Moving Average$ 51.0348
21 Day Extended Moving Average$ 50.2352
50 Day Moving Average$ 47.1978
50 Day Extended Moving Average$ 48.1455
200 Day Moving Average$ 42.1257
200 Day Extended Moving Average$ 43.3901
10 Day Average Volume377,743
20 Day Average Volume453,390
30 Day Average Volume502,441
50 Day Average Volume481,350
Alpha-0.014855
Beta1.1549
Standard Deviation0.159466
R20.151521
7 Day Price Change$ 0.41
7 Day Percent Change0.83%
21 Day Price Change$ -3.03
21 Day Percent Change-5.76%
30 Day Price Change$ 0.92
30 Day Percent Change1.89%
Month to Date Price Change$ 0.06
Month to Date Percent Change0.12%
Quarter to Date Price Change$ 7.60
Quarter to Date Percent Change18.11%
180 Day Price Change$ 8.62
180 Day Percent Change21.06%
200 Day Price Change$ 13.95
200 Day Percent Change39.17%
Year to Date Price Change$ 11.42
Year to Date Percent Change29.94%

Sage Therapeutics Inc. (SAGE) Key Ratios

PROFITABILITY
EBIT Margin-6,166.0%
EBITDA Margin-6,153.8%
Pre-Tax Profit Margin-122.9%
Profit Margin Count-44.57%
Gross Margin95.9%
Profit Margin TOT-44.57%
INCOME STATEMENTS
Revenue$ 3,294,000
Revenue Per Share$ 0.0551
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.60
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio14.20
Leverage Ratio1.10
Quick Ratio13.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 1,844,086,247
Price to Sales310.41
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book2.60
Price To Cash Flow-4.80
PE Low Last 5 Years0.00
Price to Tangible Book2.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-38.14
Return on Equity-40.60
Return on Capital-41.70

Sage Therapeutics Inc. (SAGE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
Auditor-
CEOBarry E. Greene
Employees471
Last Audit-
CIK0001597553
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address215 First Street
Cambridge, MA 2142
Websitehttp://www.sagerx.com
Facsimile+1 617 299-8379
Telephone+1 617 299-8380
EmailJeff.Boyle@sagerx.com


Your Recent History
NASDAQ
SAGE
Sage Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.